Pure Global AI
NCT06224426Recruiting

Oxygen Concentration Target in Stroke Endovascular Treatment

Oxygenation Targets for Endovascular Therapy in Acute Ischemic Stroke Patients (Oxy-TARGET)
Beijing Tiantan HospitalClinicalTrials.govother
Verified
Study focus
Disease/Condition
Ischemic Stroke
Drug/Device/Intervention
Normobaric high-concentration oxygen
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Beijing Tiantan Hospital
Location
Beijing, China
Timeline & enrollment
Phase
N/A
Start date
Feb 01, 2024
End date
Dec 31, 2026
Enrollment
200 participants
Primary outcome

the incidence of early neurological improvement (ENI)

Summary

The goal of this clinical trial is to compare the effects of different concentrations of
 normobaric oxygen on early neurological improvement in acute ischemic stroke (AIS) patients
 receiving endovascular therapy (EVT). The main questions it aims to answer are:
 
 - Evaluating the impact of normobaric high-concentration oxygen versus low-concentration
 oxygen on early neurological function after EVT.
 
 - Evaluating the safety of high and low normobaric oxygen concentration in patients with
 ischemic stroke.
 
 Participants will (1) receive EVT under general anesthesia; (2) be randomly assigned 1:1 to
 receive oxygen therapy with FiO2=80% or FiO2=30% through endotracheal intubation during the
 operation, and the gas flow rate was set at 4L /min.

ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionCerebral infarction, unspecifiedOther cerebral infarction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06224426
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06224426 through Pure Global AI's free database. This phase not specified trial is sponsored by Beijing Tiantan Hospital and is currently Recruiting. The study focuses on Ischemic Stroke. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.